(Q51757220)

11 April 2018

title

1-Methyl-4-phenylpyridinium uptake by human and rat striatal synaptosomes. (English)

1 reference

11 April 2018

1 reference

3

Hardy JA

1 reference

11 April 2018

Willoughby J

1

1 reference

11 April 2018

Cowburn RF

series ordinal

2

1 reference

11 April 2018

Glover V

series ordinal

4

1 reference

11 April 2018

Sandler M

series ordinal

5

1 reference

11 April 2018

language of work or name

English

0 references

publication date

1 February 1989

1 reference

11 April 2018

Journal of Neurochemistry

published in

1 reference

11 April 2018

volume

52

1 reference

11 April 2018

issue

2

1 reference

11 April 2018

page(s)

627-631

1 reference

11 April 2018

Neurochemical and behavioral effects of systematic and intranigral administration of N-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in the rat

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Chronic parkinsonism secondary to intravenous injection of meperidine analogues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Metabolic and secretory processes in nerve-endings isolated from post-mortem brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

A rapid method for preparing synaptosomes: comparison, with alternative procedures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Monoamine oxidase B(MAO-B) is the major catalyst for 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) oxidation in human brain and other tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Metabolic and functional studies on post-mortem human brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Parkinsonism-inducing neurotoxin, N-methyl-4-phenyl-1,2,3,6 -tetrahydropyridine: uptake of the metabolite N-methyl-4-phenylpyridine by dopamine neurons explains selective toxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced parkinsonism in the common marmoset.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Differences in the metabolism of MPTP in the rodent and primate parallel differences in sensitivity to its neurotoxic effects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

The importance of the ‘4–5’ double bond for neurotoxicity in primates of the pyridine derivative MPTP

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Intraneuronal generation of a pyridinium metabolite may cause drug-induced parkinsonism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Release of endogenous dopamine, 3,4-dihydroxyphenylacetic acid, and amino acid transmitters from rat striatal slices

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

Immunocytochemical localization of monoamine oxidases A and B in human peripheral tissues and brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1471-4159.1989.TB09165.X

10.1111/J.1471-4159.1989.TB09165.X

21 January 2018

Identifiers

DOI

1 reference

11 April 2018

1 reference

11 April 2018